| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |